Showing results (91-100 of 685) with videos related to

Sort By:
Pageof 69
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Histochemical examination of expression of ras p21 protein and R 1881-binding protein in human prostatic cancersH Sumiya, M Masai, S Akimoto, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|March 1, 1993
[Determination of tumor marker doubling time in the patients with prostate cancer relapsed from endocrine therapy]S Akimoto, M Masai, N Kitagawa, et al.
The Prostate|January 1, 1992
Argyrophilic nucleolar organizer regions in benign hyperplastic and cancerous human prostatesM Masai, K Abe, S Akimoto, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|May 1, 1991
[Clinical course of bone metastases by prostatic cancer studies with conventional X-ray]T Higa, S Akimoto, S Isaka, et al.
The Prostate|January 1, 1987
Modalities of chemotherapy and endocrine therapy for growth inhibition of androgen-stimulated mouse carcinoma (Shionogi carcinoma 115)S Hara, T Ichikawa, S Akimoto, et al.
Cancer Research|August 15, 1990
Paracrine growth stimulation of androgen-responsive Shionogi Carcinoma 115 by its autonomous subline (Chiba Subline 2)Y Furuya, N Sato, K Akakura, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|July 1, 1992
[Relationship between extent of bone metastases and effect of endocrine therapy evaluated with bone scintigraphy in stage D2 prostatic cancer]M Tanaka, S Murakami, S Akimoto, et al.
Hinyokika Kiyo. Acta Urologica Japonica|May 1, 1992
Inverted papilloma of the renal pelvis associated with renal cell carcinoma: a case reportT Ueda, S Akimoto, J Shimazaki, et al.
Advances in Experimental Medicine and Biology|January 1, 1992
Clinical course of bone metastasis from prostatic cancer following endocrine therapy: examination with bone x-rayJ Shimazaki, T Higa, S Akimoto, et al.
Hinyokika Kiyo. Acta Urologica Japonica|June 1, 1990
[Factors influencing prognosis of stage D2 prostatic cancer following endocrine therapy: comparison between short-term cancer death and long-term survival group]M Masai, S Akimoto, S Isaka, et al.
Pageof 69